Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: | Mometasone |
Active Ingredient: | Mometasone furoate monohydrate 0.5173mg/g |
Dosage Form: | Nasal spray suspension |
New Zealand Sponsor: | Neo Pharma Limited |
Manufacturer: | Farmea, Angers, France |
Product: | Mytolac |
Active Ingredient: | Lanreotide acetate 27.3%w/w equivalent to lanreotide 60mg |
Dosage Form: | Solution for injection |
New Zealand Sponsor: | Boucher & Muir (NZ) Limited t/a Mercury Pharma (NZ) |
Manufacturers: | Pharmathen SA, Pallini, Greece Synergy Health Ede B.V., Ede, Netherlands Pharmathen International SA, Rodopi, Greece Sterigenics Belgium (Fleurus) SA, Fleurus, Belgium |
Product: | Mytolac |
Active Ingredient: | Lanreotide acetate 27.3%w/w equivalent to lanreotide 90mg |
Dosage Form: | Solution for injection |
New Zealand Sponsor: | Boucher & Muir (NZ) Limited t/a Mercury Pharma (NZ) |
Manufacturers: | Pharmathen SA, Pallini, Greece Synergy Health Ede B.V., Ede, Netherlands Pharmathen International SA, Rodopi, Greece Sterigenics Belgium (Fleurus) SA, Fleurus, Belgium |
Product: | Mytolac |
Active Ingredient: | Lanreotide acetate 27.3%w/w equivalent to lanreotide 120mg |
Dosage Form: | Solution for injection |
New Zealand Sponsor: | Boucher & Muir (NZ) Limited t/a Mercury Pharma (NZ) |
Manufacturers: | Pharmathen SA, Pallini, Greece Synergy Health Ede B.V., Ede, Netherlands Pharmathen International SA, Rodopi, Greece Sterigenics Belgium (Fleurus) SA, Fleurus, Belgium |
Product: | Telnasal Allergy Spray |
Active Ingredient: | Mometasone furoate monohydrate 0.5173mg/g |
Dosage Form: | Nasal spray suspension |
New Zealand Sponsor: | Neo Pharma Limited |
Manufacturer: | Farmea, Angers, France |
Dated this 11th day of November 2022.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).